PNN JournalWatch — 8.7.23
Lancet: Efficacy and Safety of Oral Orforglipron in Patients With Type 2 Diabetes: A Multicentre, Randomised, Dose-Response, Phase 2 Study American Journal of Psychiatry: Treatment
Lancet: Efficacy and Safety of Oral Orforglipron in Patients With Type 2 Diabetes: A Multicentre, Randomised, Dose-Response, Phase 2 Study American Journal of Psychiatry: Treatment
New England Journal of Medicine: Artificial Intelligence in U.S. Health Care Delivery Diabetes Care: The Growing Role of Technology in the Care of Older Adults
New England Journal of Medicine: Obesity in Adolescents Lancet: The Unfinished Agenda of Communicable Diseases Among Children and Adolescents Before the COVID-19 Pandemic, 1990–2019: A
Lancet: Atezolizumab Plus Cabozantinib Versus Cabozantinib Monotherapy for Patients With Renal Cell Carcinoma After Progression With Previous Immune Checkpoint Inhibitor Treatment (CONTACT-03): A Multicentre, Randomised,
Journal of the American College of Cardiology: Cardiovascular Outcomes in Patients With Diabetes and Kidney Disease: JACC Review Topic of the Week American Journal of Kidney Diseases:
Annals of Internal Medicine — Demonstration Project of Long-Acting Antiretroviral Therapy in a Diverse Population of People With HIV Annals of Internal Medicine — Effects
Diabetes Care: Metformin for Treatment of Acute COVID-19: Systematic Review of Clinical Trial Data Against SARS-CoV-2 Diabetes Care: Insulin Use in Type 2 Diabetes and
Lancet: Relationship Between Clinic and Ambulatory Blood Pressure and Mortality: An Observational Cohort Study in 59,124 Patients Lancet: 6-Month Consequences of COVID-19 in Patients Discharged
Vaccine: Aiming Too High: Shoulder Injury Related to Vaccine Administration (SIRVA): A Case Series Vaccine: Prevalence of Pain and Fear as Barriers to Vaccination in
Lancet: Cognitive Functional Therapy With or Without Movement Sensor Biofeedback Versus Usual Care for Chronic, Disabling Low Back Pain (RESTORE): A Randomised, Controlled, Three-Arm, Parallel